Publications relevant for professional achievements obtained after conferring the title of doctor in sciences
IF = Impact factor (2012); IS = Influence score of journals indexed in ISI Thomson Reuters (2012); Number of citations in Web of Science 159. HIRSCH INDEX 7. PhD Thesis Grdinaru Daniela, 1998.Research regarding the expression and regulation of glucuronidation enzymes in the cerebral ageing. University of Bucharest. Scientific coordinator: Prof. Dr. Dana Iordchescu.
Books chapters printed by international publishing houses 1. Dinischiotu A, Stanca L, Grdinaru D, Petrache SN, Radu M, erban AI - Lipid peroxidation due to in vitro and in vivo exposure of biological samples to nanoparticles Oxidative Stress and Nanotechnology - Methods and Protocols, Series: Methods in Molecular Biology, Vol. 1028, Armstrong Donald; Bharali Dhruba J (Eds.) Springer Protocols, Humana Press, 2013;1028:155-64. (www.springer.com/chemistry/biotechnology/book/978-1-62703- 474-6). 2. Bora C., Ionescu C., Grdinaru D* - Oxidized LDL and NO synthesis as biomarkers of atherogenesis. Correlations with metabolic profile in elderly. In: Parthasarathy S, editor. Atherogenesis. InTech Open Access Publisher; 2012, 473-494. Available at: http://www.intechopen.com/books/atherogenesis/oxidized-ldl-and-no-synthesis-as- biomarkers-of-atherogenesis-correlations-with-metabolic-profile-in- * Corresponding author
3. Minn A., El-Bacha R.S., Bayol- Denizot C., Lagrange P., Suleman F.G., Grdinaru D. - Drug metabolism in the brain: benefits and risks, Blood- Brain and Drug Delivery on the CNS Begley D., Bradbury M.W. and Kreuter J., Eds., Marcel Dekker, New York, 2000, 145-170.
4. Minn A., Grdinaru D., Chat M., Bayol-Denizot C., Lagrange P. - Drug metabolizing enzyme activities in an in vitro model of rat blood-brain barrier, Drug Transport Across the Blood-Brain Barrier: In Vitro and In Vivo Techniques, A.G. de Boer & W. Sutanto, Eds., Harwood Academic Publishers, Amsterdam, 1997, 37-47.
2
I N EXTENSO ARTICLES PUBLISHED IN INTERNATIONAL SCIENTIFIC FLUX ISI, Scopus and PubMed indexed Articles 1. Grdinaru D*, Bora C, Ionescu C, Margin D - Advanced oxidative and glycoxidative protein damage markers in elderly with type 2 diabetes. Journal of Proteomics, 2013, [Epub ahead of print], Elsevier. IF = 4,088; IS = 1,66389 * Corresponding author
2. Margin D, Grdinaru D, Manda G, Neagoe I, Ilie M Membranar effects exerted in vitro by polyphenols quercetin, epigallocatechin gallate and curcumin on HUVEC and Jurkat cells, relevant for diabetes mellitus. Food and Chemical Toxicology, 2013, [Epub ahead of print], Elsevier. IF = 3,010; IS = 1,95098 3. Grdinaru D*, Bora C, Ionescu C, Margin D, Prada GI, Jansen E - Vitamin D status and oxidative stress markers in elderly with impaired fasting glucose and type 2 diabetes mellitus, Aging Clinical and Experimental Research. 2012, 24, 596 602. IF = 1,006; IS = 0,69621; 1 citation * Corresponding author
4. Grdinaru D*, Minn AL, Artur Y, Minn A, Heydel JM - Effect of oxidative stress on UDP- glucuronosyltransferases in rat astrocytes, Toxicology Letters. 2012, 213(3):316-24. IF = 3,145; IS = 1,42903 * Corresponding author
5. Margin D, Ilie M, Grdinaru D - Quercetin and epigallocatechin gallate induce in vitro a dose-dependent stiffening and hyperpolarizing effect on the cell membrane of human mononuclear blood cells, International Journal of Molecular Sciences. 2012;13(4):4839-59. IF = 2,464; IS = 1,60778; 1 citation 6. Margin D, Ilie M, Manda G, Neagoe I, Mocanu M, Ionescu D, Grdinaru D, Ganea C - Quercetin and epigallocatechin gallate effects on the cell membranes biophysical properties correlate with their antioxidant potential, General Physiology and Biophysics. 2012, (1):47-55. IF = 0,852; IS = 0,41990; 4 citations 7. Margin D, Grdinaru D, Panaite C, Cimponeriu D, Vldic M, Dnciulescu R, Mitrea N - The association of adipose tissue markers for redox imbalance and the cardio-vascular risk in obese patients, HealthMED Journal. 2011, 5,1, 194-199. IF = 0,435 8. Breusing N, Grune T, Andrisic L, Atalay M, Bartosz G, Biasi F, Borovic S, Bravo L, Casals I, Casillas R, Dinischiotu A, Drzewinska J, Faber H, Fauzi NM, Gajewska A, Gambini J, Grdinaru D, Kokkola T, Lojek A, Luczaj W, Margin D, Mascia C, Mateos R, Meinitzer A, Mitjavila MT, Mrakovcic L, Munteanu MC, Podborska M, Poli G, Sicinska P, Skrzydlewska E, Vina J, Wiswedel I, Zarkovic N, Zelzer S, Spickett CM - An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples, Free Radial Research. 2010, 44(10):1203-15. IF = 3,279; IS = 0,86844; 19 citations
9. Margin D, Ilie M, Negrei C, Grdinaru D, Blnescu A, Mitrea N - Quercetin and epigallocatechin gallate in vitro induced changes in the membrane anisotropy of peripheral blood mononuclear cells from patients with inflammatory diseases, Journal of Medicinal Plants Research, 2010, 4(22), 2388-2392. IF = 0,590; 1 citation
3
10. Grdinaru D*, Minn AL, Artur Y, Minn A, Heydel JM Drug metabolizing enzyme expression in rat choroid plexus: effects of in vivo xenobiotics treatment, Archives of Toxicology. 2009, 83, 581-586. IF = 5,215; IS = 1,0500; 6 citations * Corresponding author
11. Grdinaru D*, Margin D, Bora C - In vitro studies regarding the antioxidant effects of procaine, Gerovital H3 and Aslavital, Revue Roumaine de Chimie, 2009, 54(9), 761-766. IF = 0,331 * Corresponding author
12. Grdinaru D*, Mitrea N, Margin D, Arsene A, Gruia V, Drgoi C, Nicolae A, Bora C, Gherasim P Evaluation of serum osteocalcin in elderly patients with type-2 diabetes mellitus, Farmacia. 2009, 57, 3, 331-339. IF = 0,578; 5 citations * Corresponding author
13. Margin D, Vldic M, Dnciulescu R, Grdinaru D, Mitrea N - Comparison of different assessment models of insulin resistance in Romanian obese patients, Farmacia. 2009, 57, 6, 711-720. IF = 0,578
14. Ilie M, Margin D, Katona E, Ganea C, Pencea C, Vldic M, Grdinaru D, Mitrea N, Bllu D - Quercetin and epigallocatechin gallate effect on the lipid order parameter of peripheral blood mononuclear cells from diabetes patients, Romanian Biotechnological Letters. 2009, 14, 6, 4804-4811. IF = 0,363
15. Margin D, Grdinaru D*, Mitrea N - Development of a potentiometric method for the evaluation of redox status in human serum, Revue Roumaine de Chimie. 2009, 54(1), 4548. IF = 0,331; 2 citations * Corresponding author
16. Gruia V, Aram C, Mitrea N, Arsene A, Grdinaru D, Drgoi C The HPLC plasmatic profile of some fat-soluble antioxidant micronutrients (all-trans-retinol, -tocopherol, coenzyme Q10) in diabetic and dyslipidemic patients, Farmacia. 2009, 57, 5, 630 638. IF = 0,578; 2 citations
17. Margin D, Mitrea N, Grdinaru D, Vldic M, Dnciulescu R The influence of thiazolidinediones on markers of the endothelial status at type II diabetes mellitus patients, Farmacia. 2008, vol LVI, 1, 99-106. IF = 0,578; 1 citation
18. Gruia V, Arsene-Niulescu A, Mohora M, Mitrea N, Grdinaru D, Margin D, Begona YM - Correlations between some plasmatic redox parameters in diabetic pacients, Farmacia. 2008, LVI, 6, 692-696. IF = 0,578; 2 citations
19. Margin D, Vldic M, Dnciulescu R, Grdinaru D, Mitrea N - Clinical study regarding the influence of hygieno-dietetic regimen on hyperglicemic overweight patients, Archives of the Balkanic Medical Union. 2005, 40, 3, 162-166.
20. Margin D, Vldic M, Dnciulescu R, Grdinaru D, Mitrea N - Adiponectin level and NO synthesis as atherogenic markers in overweight and obese patients, (Pharmacia) Bulgaria. 2005, LII, 1-2, 68-70. IF = 0,840
4
21. Heurtaux T, Benani A, Bianchi A, Moindrot, Grdinaru D, Magdalou J, Netter P, Minn A Redox state alteration modulates astrocyte glucuronidation, Free Radical Biology & Medicine. 2004, 37, 1051 1063. IF = 5,271; 9 citations
22. Margin D, Grdinaru D, Mitrea N Clinical study regarding the atherogenic properties of the oxidatively modified low-density lipoproteins, Archives of the Balkanic Medical Union. 2004, 39, 2, 78-83.
23. Leclerc S, Heydel JM, Amosse V, Grdinaru D, Cattarelli M, Artur Y, Goudonnet H, Magdalou J, Netter P, Pelczar H, Minn A Glucuronidation of odorant molecules in the rat olfactory system. Activity, expression and age-linked modications of UDP- glucuronosyltransferase isoforms, UGT1A6 and UGT2A1, and relation to mitral cell activity, Molecular Brain Research. 2002, 107, 201-213. IF = 2,879; IS = 0,87003; 15 citations
24. Minn A, Leclerc S, Heydel JM, Minn AL, Denizot C, Cattarelli M, Netter P, Grdinaru D Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier, Journal of Drug Targeting. 2002, 10, 4, 285-296. IF = 2.768; IS = 1,13922; 39 citations
25. Heydel JM, Leclerc S, Bernard P, Pelczar H, Grdinaru D, Magdalou J, Minn A, Artur Y, Goudonnet H Rat olfactory bulb and epithelium UDP-glucuronosyltransferase 2A1 (UGT2A1) expression: in situ mRNA localization and quantitative analysis, Molecular Brain Research. 2001, 90, 83-92. IF = 2,879; IS = 0,87003; 21 citations 26. Grdinaru D, Suleman FG, Leclerc S, Heydel JM, Grillasca JP, Magdalou J, Minn A UDP-Glucuronosyltransferase in the rat olfactory bulb: identification of the UGT1A6 isoform and age-related changes in 1-naphthol glucuronidation, Neurochemical Research. 1999, 24, 8, 995-1000. IF = 2,125; IS = 0,74283; 12 citations 27. Rusu C, Bora C, Grdinaru D, Ionescu C - Oxidative damage in vivo and possible interactions between vitamin E and cellular electron transfer systems, Romanian Journal of Gerontology and Geriatrics. 1999, 21, 7-17.
28. Suleman FG, Abid A, Grdinaru D, Daval JL, Magdalou J, Minn A - Identification of the uridine diphosphate glucuronosyltransferase isoform UGT1A6 in the rat brain and in primary cultures of neurons and astrocytes, Archives of Biochemistry and Biophysics. 1998, 358, 63-67. IF = 3,370; IS = 1,01704; 38 citations
Conference papers presented at international scientific meetings, published in special issues of ISI indexed journals
I n extenso published articles:
1. Revnic F, Revnic CR, Nica A, Ginghina C, Prada G, Grdinaru D, Prada S, Sonea C, Pena C Evaluation of Matrix Metalloproteinase-9 (MMP-9) and its tissue inhibitor of metalloproteinase-1 (Timp-1) in patients with coronary syndromes after percutaneous intervention (PCI), Coronary Artery Disease: 2011 Update Proceedings of the 9th International Congress on Coronary Artery Disease, Venice, Italy, October 23-26, 2011, 49-53.
5
2. Revnic CR, Nica AS, Prada G, Grdinaru D, Sonea A, Pena C, Prada S, Revnic F Carotid Doppler Ultrasound in elderly diabetes and non-diabetes patients, Coronary Artery Disease: 2011 Update Proceedings of the 9th International Congress on Coronary Artery Disease, Venice, Italy, October 23-26, 2011, 193-197.
Abstracts:
OXIDATIVE STRESS AND XENOBIOTIC DETOXIFICATION ENZYMES IN RAT ASTROCYTES: CORRELATIONS WITH BRAIN AGING D. Grdinaru, A.L. Minn, Y. Artur, J.-M. Heydel Experimental Gerontology, Volume 48, Issue 7, July 2013, Page 688. Proceedings of the Eleventh International Symposium on the Neurobiology and Neuroendocrinology of Aging, July 29 - August 3 2012, Bregenz, Austria
INHIBITION OF SERUM LIPID AND LDL OXIDATION BY GEROVITAL H3 C. Bora, G.I. Prada, C. Ionescu, D. Margina, D. Grdinaru Experimental Gerontology, Volume 48, Issue 7, July 2013, Pages 684-685. Proceedings of the Eleventh International Symposium on the Neurobiology and Neuroendocrinology of Aging, July 29 - August 3 2012, Bregenz, Austria
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY UPON MMP2, MMP9 AND NOX1 RELEASE IN PATIENTS WITH STABLE ANGINA C. Revnic, C. Ginghin, A. Mereu, D. Grdinaru, F. Revnic Atherosclerosis Suppl., 2011, 12 (1), page 88 9th International Congress on Coronary Artery Disease, 23-26 October 2011, Venice, Italy
THE IMPACT OF PERCUTANEOUS CORONARY INTERVENTION (PCI) WITH STENT IMPLANTATION UPON MMP9 AND INFLAMATORY MARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROMES F. Revnic, C.R. Revnic, C. Ginghin, A. Mereu, D. Grdinaru, G. Prada, S. Prada, C. Pena, C. Bora, C. Ionescu Atherosclerosis Suppl., 2011, 12 (1), page 101 9th International Congress on Coronary Artery Disease, 23-26 October 2011, Venice, Italy
IN VITRO EVALUATIONS REGARDING SERUM REDOX STRESS PARAMETERS IN INVESTIGATING AGING AND OXIDOPATHIES D. Grdinaru, D. Margin Turkiye Klinikleri Journal of Medical Sciences, 2009, 29 (Suppl.): S6 II Congress Anti-Aging & Aesthetic Medicine Society, 22-25 October 2009, Izmir, Turkey
ASLAN THERAPY (INSTITUTE): THE FIRST ANTI-AGING TREATMENT AS A MODEL IN THE WORLD D. Grdinaru Turkiye Klinikleri Journal of Medical Sciences, 2009, 29 (Suppl.): S116 II Congress Anti-Aging & Aesthetic Medicine Society, 22-25 October 2009, Izmir, Turkey
STUDIES REGARDING PARAQUAT EFFECT ON PHASE I AND II DRUG METABOLIZING ENZYMES EXPRESSION IN RAT BRAIN D. Grdinaru, D. Margin, A.L. Arsene, Mitrea N. Toxicology Letters, 2008, 180 (Suppl. 1): S165
6
45th Congress of the European-Societies-of-Toxicology, 5 8 October 2008, Rhodes, Greece
IMMUNE RESPONSE IN HEALTHY AGEING: IMMUNOSENESCENCE VERSUS IMMUNODEFICIENCY M. Neagu, C. Constantin, G. Manda G, D. Grdinaru, Ursaciuc C. FEBS Journal, 2008, 275 (Suppl. 1), page 210 Joint Conference of the 33rd FEBS Congress/11th IUBMB Conference, 28 June 3 July 2008, Athens, Greece
REDOX STRESS PARAMETERS IN TYPE 2 DIABETES MELLITUS M. Vladic, D. Margin, D. Grdinaru Diabetologia, 2007, 50(Suppl. 1): S298 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, 18-21 September 2007, Amsterdam, Netherlands
THE RESPIRATORY BURST EVALUATION BY FLOW CYTOMETRY IN NORMAL ELDERLY SUBJECTS C. Constantin, D. Grdinaru, G. Manda Cytometry, Part B-Clinical Cytometry, 2007, 72B(2):143 6th Euroconference on Clinical Cell Analysis, 14-16 September 2006 Stresa, Italy
CORRELATION BETWEEN METABOLIC PROFILE, INSULIN RESISTANCE AND OXIDATIVE METABOLIC STATUS IN ELDERLY WOMEN WITH AND WITHOUT TYPE 2 DIABETES C. Rusu, D. Grdinaru, C. Bora, D. State, M. Georgescu Diabetes & Vascular Disease Research (indexed EMBASE), 2005, 2,163 3-th Annual World Congress on Insulin Resistance Syndrome, 17-19 November 2005, San Francisco, USA.